Pulmonx (LUNG) Equity Ratio (2019 - 2025)
Pulmonx (LUNG) reported Equity Ratio of 0.42 for Q4 2025, down 20.56% year-over-year from 0.53 in Q4 2024, and down 3.59% on a QoQ basis from 0.43 in Q3 2025.
Pulmonx (LUNG) has 7 years of Equity Ratio data on file, last reported at 0.42 in Q4 2025.
- Quarterly Equity Ratio fell 20.56% year-over-year to 0.42 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.42 (down 20.56% YoY) and the FY2025 annual result came in at 0.42, down 20.56% from the prior year.
- Equity Ratio eased to 0.42 in Q4 2025 per LUNG's latest filing, from 0.43 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.85 in Q1 2021 and bottomed at 0.42 in Q4 2025.
- The 5-year median for Equity Ratio is 0.69 (2023), against an average of 0.67.
- The widest annual swing landed in 2021, when Equity Ratio jumped 128.3%; it then fell 23.25% in 2025.
- Tracing LUNG's Equity Ratio over 5 years: stood at 0.82 in 2021, then fell by 3.23% to 0.8 in 2022, then dropped by 16.31% to 0.67 in 2023, then retreated by 20.82% to 0.53 in 2024, then retreated by 20.56% to 0.42 in 2025.
- Per Business Quant, the three latest LUNG Equity Ratio figures stand at 0.42 (Q4 2025), 0.43 (Q3 2025), and 0.47 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | 0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.67 |
| Dec 31, 2023 | 0.67 |
| Sep 30, 2023 | 0.68 |
| Jun 30, 2023 | 0.69 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.80 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 0.81 |
| Mar 31, 2022 | 0.82 |
| Dec 31, 2021 | 0.82 |
| Sep 30, 2021 | 0.82 |
| Jun 30, 2021 | 0.84 |
| Mar 31, 2021 | 0.85 |
| Dec 31, 2020 | 0.86 |
| Sep 30, 2020 | -2.90 |
| Dec 31, 2019 | -3.50 |